经参考大量文献,对新喹诺酮类药物(本研究将第三、四代统称为新喹诺酮类药物)在治疗结核病中的应用情况进行探讨。新喹诺酮类药物具有良好抗结核作用,是一种使用安全、副反应小的新一代的抗结核药物。但存在一系列不良反应,应注意选择适应病例,通过皮试、控制用药剂量、给药速度、药物配伍等进行防范。 With reference to a large number of literatures, the application of new quinolones (the third and fourth generations of this study are collectively referred to as new quinolones) in the treatment of tuberculosis were discussed. The new quinolones have a good anti-TB effect and are a new generation of anti-TB drugs that are safe to use and have little side-reaction. However, there are a series of adverse reactions, should pay attention to choose to adapt to the case, through the skin test, control dosage, drug delivery rate, drug compatibility, etc. to prevent.